This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2016 Sep 8;537(7619):S63.

doi: 10.1038/537S63a.

Perspective: The precision-oncology illusion

Affiliations

PMID: 27602743
DOI: 10.1038/537S63a

Perspective: The precision-oncology illusion

Vinay Prasad. Nature. 2016.

. 2016 Sep 8;537(7619):S63.

doi: 10.1038/537S63a.

Author

Affiliation

¹ Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.

PMID: 27602743
DOI: 10.1038/537S63a

No abstract available

PubMed Disclaimer

Comment in

Molecular medicine: Precision oncology is not an illusion.
Abrahams E, Eck SL. Abrahams E, et al. Nature. 2016 Nov 17;539(7629):357. doi: 10.1038/539357e. Nature. 2016. PMID: 27853199 No abstract available.

Similar articles

Precision Medicine in Oncology II: Economics of Targeted Agents and Immuno-Oncology Drugs.
Huntington SF, Davidoff AJ, Gross CP. Huntington SF, et al. J Clin Oncol. 2020 Feb 1;38(4):351-358. doi: 10.1200/JCO.19.01573. Epub 2019 Dec 5. J Clin Oncol. 2020. PMID: 31804866 Review. No abstract available.
Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice.
Beer PA, Cooke SL, Chang DK, Biankin AV. Beer PA, et al. Ann Oncol. 2019 Nov 1;30(11):1691-1694. doi: 10.1093/annonc/mdz392. Ann Oncol. 2019. PMID: 31665210 No abstract available.
Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
Blumenthal GM, Mansfield E, Pazdur R. Blumenthal GM, et al. JAMA Oncol. 2016 Jan;2(1):13-4. doi: 10.1001/jamaoncol.2015.4503. JAMA Oncol. 2016. PMID: 26540172 No abstract available.
Delivering on the promise of precision cancer medicine.
Berger MF, Van Allen EM. Berger MF, et al. Genome Med. 2016 Oct 25;8(1):110. doi: 10.1186/s13073-016-0373-1. Genome Med. 2016. PMID: 27782852 Free PMC article. No abstract available.
Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
Nadauld LD, Ford JM, Pritchard D, Brown T. Nadauld LD, et al. Health Aff (Millwood). 2018 May;37(5):751-756. doi: 10.1377/hlthaff.2017.1575. Health Aff (Millwood). 2018. PMID: 29733728 Review.

See all similar articles

Cited by

Combined Focused Next-Generation Sequencing Assays to Guide Precision Oncology in Solid Tumors: A Retrospective Analysis from an Institutional Molecular Tumor Board.
Tarawneh TS, Rodepeter FR, Teply-Szymanski J, Ross P, Koch V, Thölken C, Schäfer JA, Gremke N, Mack HID, Gold J, Riera-Knorrenschild J, Wilhelm C, Rinke A, Middeke M, Klemmer A, Romey M, Hattesohl A, Jesinghaus M, Görg C, Figiel J, Chung HR, Wündisch T, Neubauer A, Denkert C, Mack EKM. Tarawneh TS, et al. Cancers (Basel). 2022 Sep 12;14(18):4430. doi: 10.3390/cancers14184430. Cancers (Basel). 2022. PMID: 36139590 Free PMC article.
Update on emerging biomarkers in lung cancer.
Bernicker EH, Allen TC, Cagle PT. Bernicker EH, et al. J Thorac Dis. 2019 Jan;11(Suppl 1):S81-S88. doi: 10.21037/jtd.2019.01.46. J Thorac Dis. 2019. PMID: 30775031 Free PMC article. Review.
Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.
Domenyuk V, Gatalica Z, Santhanam R, Wei X, Stark A, Kennedy P, Toussaint B, Levenberg S, Wang J, Xiao N, Greil R, Rinnerthaler G, Gampenrieder SP, Heimberger AB, Berry DA, Barker A, Quackenbush J, Marshall JL, Poste G, Vacirca JL, Vidal GA, Schwartzberg LS, Halbert DD, Voss A, Magee D, Miglarese MR, Famulok M, Mayer G, Spetzler D. Domenyuk V, et al. Nat Commun. 2018 Mar 23;9(1):1219. doi: 10.1038/s41467-018-03631-z. Nat Commun. 2018. PMID: 29572535 Free PMC article.
The evidence framework for precision cancer medicine.
Moscow JA, Fojo T, Schilsky RL. Moscow JA, et al. Nat Rev Clin Oncol. 2018 Mar;15(3):183-192. doi: 10.1038/nrclinonc.2017.186. Epub 2017 Dec 19. Nat Rev Clin Oncol. 2018. PMID: 29255239 Review.
Precision oncology using ex vivo technology: a step towards individualised cancer care?
Williams ST, Wells G, Conroy S, Gagg H, Allen R, Rominiyi O, Helleday T, Hullock K, Pennington CEW, Rantala J, Collis SJ, Danson SJ. Williams ST, et al. Expert Rev Mol Med. 2022 Oct 3;24:e39. doi: 10.1017/erm.2022.32. Expert Rev Mol Med. 2022. PMID: 36184897 Free PMC article. Review.

See all "Cited by" articles

References

1. Mayo Clin Proc. 2015 Dec;90(12):1639-49 - PubMed
1. J Clin Oncol. 2015 Sep 1;33(25):2753-62 - PubMed
1. Lancet Oncol. 2015 Oct;16(13):1324-34 - PubMed
1. Science. 2012 Oct 12;338(6104):221 - PubMed
1. JAMA Oncol. 2016 Nov 1;2(11):1452-1459 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information